# Effect of Mirabegron on Bladder Compliance

> **NCT05745584** · NA · UNKNOWN · sponsor: **Yonsei University** · enrollment: 15 (estimated)

## Conditions studied

- Patients With Low Bladder Compliance of 20ml/H2O or Less Despite Taking Anticholinergics

## Interventions

- **DRUG:** Mirabegron (beta3-adrenoceptor agonist), Anticholinergics

## Key facts

- **NCT ID:** NCT05745584
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-01-12
- **Primary completion:** 2023-03-02
- **Final completion:** 2023-03-02
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2023-02-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05745584

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05745584, "Effect of Mirabegron on Bladder Compliance". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT05745584. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*